BRAF and metastatic malignant neoplasm in the lymph nodes: Considering the accordingly increased risk of tumor multifocality, ETE, capsular invasion, lymph node metastasis, and disease recurrence in BRAF mutated PTMC, patients with such tumors may be appropriately recommended an intervention of moderate aggressiveness, such as minimally invasive ablative techniques.